{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:48:48Z","timestamp":1768866528507,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T00:00:00Z","timestamp":1280188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00280-010-1409-7","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T11:59:03Z","timestamp":1280145543000},"page":"1085-1100","source":"Crossref","is-referenced-by-count":40,"title":["Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis"],"prefix":"10.1007","volume":"67","author":[{"given":"C. A. C. X.","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. F. C.","family":"Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. N.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R. M. M.","family":"Barboza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A. P.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. M. N.","family":"Alencar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A. C.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,27]]},"reference":[{"key":"1409_CR1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1368-8375(01)00107-5","volume":"38","author":"J Clarke","year":"2002","unstructured":"Clarke J, Butler R, Howarth G, Read L, Regester G (2002) Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy induced mucositis in the hamster. Oral Oncol 38:478\u2013485","journal-title":"Oral Oncol"},{"key":"1409_CR2","first-page":"680","volume":"16","author":"ST Sonis","year":"2002","unstructured":"Sonis ST, Fey EG (2002) Oral complications of cancer therapy. Oncology 16:680\u2013686","journal-title":"Oncology"},{"key":"1409_CR3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00520-006-0055-4","volume":"14","author":"JA Jones","year":"2006","unstructured":"Jones JA, Avritscher EB, Cooksley CD, Michelet M, Bekele BN, Elting LS (2006) Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer 14:505\u2013515","journal-title":"Support Care Cancer"},{"key":"1409_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","volume":"66","author":"A Trotti","year":"2003","unstructured":"Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK et al (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253\u2013262","journal-title":"Radiother Oncol"},{"key":"1409_CR5","first-page":"6","volume":"5","author":"S Sonis","year":"1991","unstructured":"Sonis S, Clark J (1991) Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology 5:6\u201310","journal-title":"Oncology"},{"key":"1409_CR6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","volume":"25","author":"LS Elting","year":"1997","unstructured":"Elting LS, Rubenstein EB, Rolston KVI, Bodey GP (1997) Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25:247\u2013259","journal-title":"Clin Infect Dis"},{"key":"1409_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1601-0825.2006.01258.x","volume":"12","author":"C Scully","year":"2006","unstructured":"Scully C, Sonis S, Diz PD (2006) Oral mucositis. Oral Dis 12:229\u2013241","journal-title":"Oral Dis"},{"key":"1409_CR8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3322\/canjclin.51.5.290","volume":"51","author":"WJ K\u00f6stler","year":"2001","unstructured":"K\u00f6stler WJ, Hejna M, Wenzel C, Zielinski CC (2001) Oral mucositis complicating chemotherapy and\/or radiotherapy: options for prevention and treatment. CA Cancer Journal Clin 51:290\u2013315","journal-title":"CA Cancer Journal Clin"},{"key":"1409_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOO.0b013e3280523ad6","volume":"15","author":"N Treister","year":"2007","unstructured":"Treister N, Sonis S (2007) Mucositis: biology and management. Current Opinion in Otolaryngology & Head and Neck Surgery 15:123\u2013129","journal-title":"Current Opinion in Otolaryngology & Head and Neck Surgery"},{"key":"1409_CR10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1368-8375(00)00012-9","volume":"36","author":"ST Sonis","year":"2000","unstructured":"Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Manson L et al (2000) Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 36:373\u2013381","journal-title":"Oral Oncol"},{"key":"1409_CR11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","volume":"4","author":"ST Sonis","year":"2004","unstructured":"Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:277\u2013284","journal-title":"Nat Rev Cancer"},{"key":"1409_CR12","first-page":"483","volume":"25","author":"M Jasi\u00f1ska","year":"2007","unstructured":"Jasi\u00f1ska M, Owczarek J, Orszulak-Michalak D (2007) Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacologic Reports 25:483\u2013499","journal-title":"Pharmacologic Reports"},{"key":"1409_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.278.4.313","volume":"278","author":"PR Hebert","year":"2007","unstructured":"Hebert PR, Gaziano JM, Chan KS, Hennekens CH (2007) Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials [review]. JAMA 278:313\u2013321","journal-title":"JAMA"},{"key":"1409_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-8703(99)70340-6","volume":"138","author":"TR Pedersen","year":"1999","unstructured":"Pedersen TR (1999) Statin trials and goals of cholesterol-lowering therapy after AMI [review]. Am Heart J 138:177\u2013182","journal-title":"Am Heart J"},{"key":"1409_CR15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","volume":"97","author":"U Laufs","year":"1998","unstructured":"Laufs U, La Fata V, Plutzky J, Liao JK (1998) Up regulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129\u20131135","journal-title":"Circulation"},{"key":"1409_CR16","doi-asserted-by":"crossref","first-page":"21926","DOI":"10.1074\/jbc.274.31.21926","volume":"274","author":"U Laufs","year":"1999","unstructured":"Laufs U, Marra D, Node K, Liao JK (1999) 3-Hydroxy-3- methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J Biol Chem 274:21926\u201321931","journal-title":"J Biol Chem"},{"key":"1409_CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","volume":"103","author":"M Aikawa","year":"2001","unstructured":"Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y et al (2001) An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 103:276\u2013283","journal-title":"Circulation"},{"key":"1409_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0049-3848(99)00037-7","volume":"95","author":"G Huhle","year":"1999","unstructured":"Huhle G, Abletshauser C, Mayer N, Weidinger G, Harenberg J, Heene DL (1999) Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor. Thromb Res 95:229\u2013234","journal-title":"Thromb Res"},{"key":"1409_CR19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00041433-200212000-00005","volume":"13","author":"RS Rosenson","year":"2002","unstructured":"Rosenson RS, Brown AS (2002) Statin use in acute coronary syndromes: cellular mechanisms and clinical evidence. Curr Opin Lipidol 13:625\u2013630","journal-title":"Curr Opin Lipidol"},{"key":"1409_CR20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1358\/dot.2004.40.12.872573","volume":"40","author":"LL Stoll","year":"2004","unstructured":"Stoll LL, McCormick ML, Denning GM, Weintraub NL (2004) Antioxidant effects of statins. Drugs Today 40:975\u2013990","journal-title":"Drugs Today"},{"key":"1409_CR21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","volume":"98","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S et al (1998) Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 98:839\u2013844","journal-title":"Circulation"},{"key":"1409_CR22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tcm.2005.07.002","volume":"15","author":"C Arnaud","year":"2005","unstructured":"Arnaud C, Braunersreuther V, Mach F (2005) Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med 15:202\u2013206","journal-title":"Trends Cardiovasc Med"},{"key":"1409_CR23","doi-asserted-by":"crossref","first-page":"0001","DOI":"10.1161\/01.STR.0000143319.73503.38","volume":"35","author":"M Endres","year":"2004","unstructured":"Endres M, Laufs U (2004) Effects of statins on endothelium and signaling mechanisms. Stroke 35:0001\u20130004","journal-title":"Stroke"},{"key":"1409_CR24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0024-3205(00)00680-9","volume":"67","author":"I Inoue","year":"2000","unstructured":"Inoue I, Goto S, Mizotani K, Awata T, Mastunaga T, Kawa S et al (2000) Lipophilic HMG-CoA reductase inhibitor has an antiinflammatory effect: reduction of MRNA levels for interleukin-1\u03b2, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor \u03b1 (PPAR \u03b1) in primary endothelial cells. Life Sci 67:863\u2013876","journal-title":"Life Sci"},{"key":"1409_CR25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","volume":"7","author":"G Weitz-Schmidt","year":"2001","unstructured":"Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C et al (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin. Nat Med 7:687\u2013692","journal-title":"Nat Med"},{"key":"1409_CR26","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/01.STR.31.10.2442","volume":"31","author":"U Laufs","year":"2000","unstructured":"Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dirnagl U et al (2000) Atorvastatin up regulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31:2442\u20132449","journal-title":"Stroke"},{"key":"1409_CR27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00280-006-0301-y","volume":"59","author":"RFC Leit\u00e3o","year":"2007","unstructured":"Leit\u00e3o RFC, Ribeiro RA, Bellaguarda EAL, Macedo FDB, Silva LR, Ori\u00e1 RB et al (2007) Role of nitric oxide on pathogenesis of 5-Fluorouracil induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol 59:603\u2013612","journal-title":"Cancer Chemother Pharmacol"},{"key":"1409_CR28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1590\/S0100-879X2003001000015","volume":"36","author":"MH Souza","year":"2003","unstructured":"Souza MH, Troncon LE, Cunha FQ, Oliveira RB (2003) Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin- induced gastric damage in rats. Braz J Med Biol Res 36:1383\u20131390","journal-title":"Braz J Med Biol Res"},{"key":"1409_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9780470110461.ch1","volume":"26","author":"EA Bayer","year":"1980","unstructured":"Bayer EA, Wilchek M (1980) The use of the avidin\u2013biotin complex as a tool in molecular biology. Meth Biochem Anal 26:1\u201345","journal-title":"Meth Biochem Anal"},{"key":"1409_CR30","first-page":"213","volume":"99","author":"JC Chen","year":"2000","unstructured":"Chen JC, Chen HM, Shyr MH, Fan LL, Chi TY, Chi CP et al (2000) Selective inhibition of inducible nitric oxide in ischemia-reperfusion of rat small intestine. J Formos Med Assoc 99:213\u2013218","journal-title":"J Formos Med Assoc"},{"key":"1409_CR31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","volume":"25","author":"J Sedlak","year":"1968","unstructured":"Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent. Anal Biochem 25:192\u2013205","journal-title":"Anal Biochem"},{"issue":"11","key":"1409_CR32","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1177\/29.11.6172466","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L (1981) Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29(11):1349\u20131353","journal-title":"J Histochem Cytochem"},{"key":"1409_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01966691","volume":"17","author":"GEP Souza","year":"1985","unstructured":"Souza GEP, Ferreira SH (1985) Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents Actions 17:97\u2013103","journal-title":"Agents Actions"},{"key":"1409_CR34","first-page":"65","volume-title":"Manual of clinical microbiology","author":"RR Murray","year":"1995","unstructured":"Murray RR, Baron EJ, Pfaller MA, Tenover FC, Volkers RH (1995) Manual of clinical microbiology. American Society Microbiology, Washington, pp 65\u201377"},{"key":"1409_CR35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0722.2005.00216.x","volume":"113","author":"V Lima","year":"2005","unstructured":"Lima V, Brito GAC, Cunha FQ, Rebou\u00e7as CG, Falc\u00e3o BAA, Augusto RF et al (2005) Effects of the tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters. Eur J Oral Sci 113:210\u2013217","journal-title":"Eur J Oral Sci"},{"key":"1409_CR36","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/01.ATV.0000037098.20829.31","volume":"22","author":"AH Wagner","year":"2002","unstructured":"Wagner AH, Gebauer M, G\u00fcldenzoph B, Hecker M (2002) 3-hydroxy-3-methylglutaryl coenzyme A reductase\u2013independent inhibition of CD40 expression by atorvastatin in human endothelial cells. Arterioscler Thromb Vasc Biol 22:1784\u20131789","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1409_CR37","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1161\/01.CIR.0000043029.52803.7B","volume":"106","author":"U Sch\u00f6nbeck","year":"2002","unstructured":"Sch\u00f6nbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U et al (2002) Oxidized low-density lipoprotein augments and 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 106:2888\u20132893","journal-title":"Circulation"},{"key":"1409_CR38","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/00007890-200105150-00014","volume":"71","author":"MM Sadeghi","year":"2001","unstructured":"Sadeghi MM, Tiglio A, Sadigh K, O\u2019Donnell L, Collinge M, Pardi R et al (2001) Inhibition of interferon-gamma mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation 71:1262\u20131268","journal-title":"Transplantation"},{"key":"1409_CR39","first-page":"1135","volume":"54","author":"ST Sonis","year":"1994","unstructured":"Sonis ST, Lindquist L, Van Vugt A, Stewart AA, Stam K, Qu GY et al (1994) Prevention of chemotherapy induced ulcerative mucositis by transforming growth factor beta-3. Cancer Res 54:1135\u20131138","journal-title":"Cancer Res"},{"key":"1409_CR40","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995\u20132025","journal-title":"Cancer"},{"key":"1409_CR41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.05.005","volume":"516","author":"MM Barsante","year":"2005","unstructured":"Barsante MM, Roffe E, Yokoro CM, Tafuri WL, Souza DG, Pinho V et al (2005) Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. Eur J Pharmacol 516:282\u2013289","journal-title":"Eur J Pharmacol"},{"key":"1409_CR42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbrc.2009.03.019","volume":"382","author":"YM Sun","year":"2009","unstructured":"Sun YM, Tian Y, Li X, Liu YY, Wang LF, Li J et al (2009) Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia reperfusion injury in rats. Biochem Biophys Res Commun 382:336\u2013340","journal-title":"Biochem Biophys Res Commun"},{"key":"1409_CR43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.plefa.2004.11.001","volume":"72","author":"KK Wu","year":"2005","unstructured":"Wu KK (2005) Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators. Prostaglandins Leukot Essent Fatty Acids 72:89\u201393","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1409_CR44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbalip.2004.11.004","volume":"1687","author":"A Planavila","year":"2005","unstructured":"Planavila A, Laguna JC, Vazquez-Carrea M (2005) Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-Kappa B activation. Biochim Biophys Acta 1687:76\u201383","journal-title":"Biochim Biophys Acta"},{"key":"1409_CR45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1471-4159.2005.03182.x","volume":"94","author":"R Prasad","year":"2005","unstructured":"Prasad R, Giri S, Nath N, Singh I, Singh AK (2005) Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B) nuclear factor-Kappa B pathway by lovastatin limits endothelial-monocyte cell interaction. J Neurochem 94:204\u2013214","journal-title":"J Neurochem"},{"key":"1409_CR46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/niox.1997.0118","volume":"2","author":"K Kr\u00f6ncke","year":"1997","unstructured":"Kr\u00f6ncke K, Fehsel K, Kolb-Bachofen V (1997) Nitric oxide: cytotoxicity versus cytoprotection\u2014how, why, when, and where? Nitric Oxide: Biol Chem 2:107\u2013120","journal-title":"Nitric Oxide: Biol Chem"},{"key":"1409_CR47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-302X.2001.160410.x","volume":"16","author":"RP Allaker","year":"2001","unstructured":"Allaker RP, Mendez LSS, Hardie JM, Benjamin N (2001) Antimicrobial effect of acidified nitrite on periodontal bacteria. Oral Microbiol Immunol 16:253\u2013256","journal-title":"Oral Microbiol Immunol"},{"key":"1409_CR48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0006-291X(05)80832-0","volume":"186","author":"C Estrada","year":"1992","unstructured":"Estrada C, Gomez C, Martin C, Moncada S, Gonzalez C (1992) Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells. Biochem Biophys Res Commun 186:475\u2013482","journal-title":"Biochem Biophys Res Commun"},{"key":"1409_CR49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1210\/en.135.1.330","volume":"135","author":"SH Ralston","year":"1994","unstructured":"Ralston SH, Todd D, Helfrich MH, Benjamin N, Grabowski P (1994) Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135:330\u2013336","journal-title":"Endocrinology"},{"key":"1409_CR50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3140109","volume":"314","author":"M Laurent","year":"1996","unstructured":"Laurent M, Lepoivre M, Tenu J (1996) Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase. Biochem J 314:109\u2013113","journal-title":"Biochem J"},{"key":"1409_CR51","first-page":"1089","volume":"4","author":"ZM Lohinai","year":"1998","unstructured":"Lohinai ZM, Szab\u00f3 C (1998) Role of nitric oxide physiology and pathophysiology of periodontal tissues. Med Sci Monit 4:1089\u20131095","journal-title":"Med Sci Monit"},{"key":"1409_CR52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1034\/j.1601-0825.2001.70102.x","volume":"7","author":"HK Kendall","year":"2001","unstructured":"Kendall HK, Marshall RI, Bartold PM (2001) Nitric oxide and tissue destruction. Oral Dis 7:2\u201310","journal-title":"Oral Dis"},{"key":"1409_CR53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.numecd.2008.10.003","volume":"19","author":"D Baldassarre","year":"2009","unstructured":"Baldassarre D, Porta B, Camera M, Amato M, Arquati M, Brusoni B et al (2009) Study group. Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment. Nutr Metab Cardiovasc Dis 19:481\u2013490","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1409_CR54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00280-007-0463-2","volume":"61","author":"RFC Leit\u00e3o","year":"2008","unstructured":"Leit\u00e3o RFC, Ribeiro RA, Lira MAS, Silva LR, Bellaguarda EAL, Macedo FDB et al (2008) Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol 61:215\u2013222","journal-title":"Cancer Chemother Pharmacol"},{"key":"1409_CR55","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0022-4804(03)00083-0","volume":"111","author":"AT Johnson","year":"2003","unstructured":"Johnson AT, Kaufmann YC, Luo S, Todorova V, Klimberg VS (2003) Effect of glutamine on glutathione, IGF-I, and TGF-\u03b21. J Surg Res 111:222\u2013228","journal-title":"J Surg Res"},{"key":"1409_CR56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/jsre.1996.0077","volume":"61","author":"R Denno","year":"1996","unstructured":"Denno R, Rounds JD, Faris R, Holejko LB, Wilmore DW (1996) Glutamine-enriched total parenteral nutrition enhances plasma glutathione in the resting state. J Surg Res 61:35\u201338","journal-title":"J Surg Res"},{"key":"1409_CR57","first-page":"147","volume":"7","author":"RA Karmali","year":"1984","unstructured":"Karmali RA (1984) Growth inhibition and prostaglandin metabolism in the R3230AC mammary adenocarcinoma by reduced glutathione. Cancer Biochem Biophys 7:147\u2013154","journal-title":"Cancer Biochem Biophys"},{"key":"1409_CR58","doi-asserted-by":"crossref","first-page":"16659","DOI":"10.1016\/S0021-9258(18)55352-7","volume":"266","author":"BJ Buckley","year":"1991","unstructured":"Buckley BJ, Kent RS, Whorton AR (1991) Regulation of endothelial cell prostaglandin synthesis by glutathione. J Biol Chem 266:16659\u201316666","journal-title":"J Biol Chem"},{"key":"1409_CR59","doi-asserted-by":"crossref","first-page":"69F","DOI":"10.1016\/j.amjcard.2005.06.028","volume":"96","author":"DD Waters","year":"2005","unstructured":"Waters DD (2005) Safety of high-dose atorvastatin therapy. Am J Cardiol 96:69F\u201375F","journal-title":"Am J Cardiol"},{"key":"1409_CR60","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(99)00569-3","volume":"353","author":"A Nakad","year":"1999","unstructured":"Nakad A, Bataille L, Hamoir V, Sempoux C, Horsmans Y (1999) Atorvastatin- induced acute hepatitis with absence of cross-toxicity with simvastatin. Lancet 353:1763\u20131764","journal-title":"Lancet"},{"key":"1409_CR61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(02)00092-2","volume":"37","author":"E Ridruejo","year":"2002","unstructured":"Ridruejo E, Mando OG (2002) Acute cholestatic hepatitis after reinitiating treatment with atorvastatin. J Hepatol 37:165\u2013166","journal-title":"J Hepatol"},{"key":"1409_CR62","first-page":"3602","volume":"51","author":"K Keyomarsi","year":"1991","unstructured":"Keyomarsi K, Sandoval L, Band V, Pardee AB (1991) Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 51:3602\u20133609","journal-title":"Cancer Res"},{"key":"1409_CR63","first-page":"10","volume":"9","author":"KK Chan","year":"2003","unstructured":"Chan KK, Oza AM, Siu LL (2003) The statins as anticancer agents. Clin Cancer Res 9:10\u201319","journal-title":"Clin Cancer Res"},{"key":"1409_CR64","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM (2005) Statins and cancer prevention. Nat Rev Cancer 5:930\u2013942","journal-title":"Nat Rev Cancer"},{"key":"1409_CR65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1593\/neo.04169","volume":"6","author":"MUR Naidu","year":"2004","unstructured":"Naidu MUR, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P (2004) Chemotherapy-induced and or radiation therapy-induced oral mucositis-complicating the treatment of cancer. Review article. Neoplasia 6:423\u2013431","journal-title":"Neoplasia"},{"key":"1409_CR66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/bja\/ael358","volume":"98","author":"CC McGown","year":"2007","unstructured":"McGown CC, Brookes ZLS (2007) Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesth 98:163\u2013175","journal-title":"Br J Anaesth"},{"key":"1409_CR67","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1378\/chest.124.2.740","volume":"124","author":"Y Almog","year":"2003","unstructured":"Almog Y (2003) Statins, Inflammation and Sepsis. Chest 124:740\u2013743","journal-title":"Chest"},{"key":"1409_CR68","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.0000129774.09737.5B","volume":"109","author":"MW Merx","year":"2004","unstructured":"Merx MW, Liehn EA, Janssens U, L\u00fctticken R, Schrader J, Hanrath P et al (2004) HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis. Circulation 109:2560\u20132565","journal-title":"Circulation"},{"key":"1409_CR69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00134-005-2859-y","volume":"32","author":"P Kruger","year":"2006","unstructured":"Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G et al (2006) Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 32:75\u201379","journal-title":"Intensive Care Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-010-1409-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1409-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T13:55:27Z","timestamp":1635774927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-010-1409-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,27]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1007\/s00280-010-1409-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,27]]}}}